O. Rauzy et al., Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases, J CL PATH-M, 51(6), 1998, pp. 333-338
Citations number
26
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Aims/Background-To assess the presence of bcl-2/J(H) rearrangements in bone
marrow and peripheral blood lymphocytes from patients affected by diseases
other than malignant lymphomas. The t(14;18) (q32;q21) translocation, whic
h juxtaposes the bcl-2 oncogene on chromosome 18 and the J(H) segment of th
e immunoglobulin heavy chain (IgH) genes on chromosome 14, is found frequen
tly in follicular lymphomas.
Methods-A sensitive semi-nested polymerase chain reaction (PCR) was used to
detect t(14;18) translocation in bone marrow aspirates and peripheral bloo
d lymphocytes from 48 patients. In 137 additional individuals peripheral bl
ood lymphocytes only were tested.
Results-Cells carrying bcl-2/J(H) rearrangements were detected in about a q
uarter of the bone marrow samples and half of the peripheral blood lymphocy
te samples. In seven patients, t(14;18) positive cells were found in both t
he bone marrow and peripheral blood lymphocyte samples. The size of the PCR
products and bcl-2/J(H) DNA sequence analysis showed that the same t(14;18
) carrying clone was present in the bone marrow and the corresponding perip
heral blood lymphocyte samples in three of these seven patients. Some patie
nts had more than one bcl-2/J(H) rearrangement. There was no significant co
rrelation between age and the translocation incidence. Cells carrying the t
(14;18) translocation were present in peripheral blood lymphocyte samples w
ith a similar incidence-between 47% and 52% in all age groups from 20 to 79
years. Patients older than 80 years had a lower (37%) but not significantl
y different incidence.
Conclusions-These findings suggest that patients affected by non-lymphoid d
iseases may have several t(14;18) carrying cells and some of them undergo a
clonal expansion. Whether individuals with t(14;18) positive cells are at
a higher risk of lymphoid malignancies remains unanswered and further epide
miological studies are required.